Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
BMC Cancer. 2011 Aug 3;11:331. doi: 10.1186/1471-2407-11-331.
Hypoxia has been identified as a major negative factor for tumor progression in clinical observations and in animal studies. However, the precise role of hypoxia in tumor progression has not been fully explained. In this study, we extensively investigated the effect of long-term exposure to hypoxia on tumor progression in vivo.
Rats bearing transplanted tumors consisting of A549 human lung cancer cells (lung cancer tumor) were exposed to hypoxia for different durations and different levels of oxygen. The tumor growth and metastasis were evaluated. We also treated A549 lung cancer cells (A549 cells) with chronic hypoxia and then implanted the hypoxia-pretreated cancer cells into mice. The effect of exposure to hypoxia on metastasis of Lewis lung carcinoma in mice was also investigated.
We found that long-term exposure to hypoxia a) significantly inhibited lung cancer tumor growth in xenograft and orthotopic models in rats, b) significantly reduced lymphatic metastasis of the lung cancer in rats and decreased lung metastasis of Lewis lung carcinoma in mice, c) reduced lung cancer cell proliferation and cell cycle progression in vitro, d) decreased growth of the tumors from hypoxia-pretreated A549 cells, e) decreased Na+-K+ ATPase α1 expression in hypoxic lung cancer tumors, and f) increased expression of hypoxia inducible factors (HIF1α and HIF2α) but decreased microvessel density in the lung cancer tumors. In contrast to lung cancer, the growth of tumor from HCT116 human colon cancer cells (colon cancer tumor) was a) significantly enhanced in the same hypoxia conditions, accompanied by b) no significant change in expression of Na+-K+ ATPase α1, c) increased HIF1α expression (no HIF2α was detected) and d) increased microvessel density in the tumor tissues.
This study demonstrated that long-term exposure to hypoxia repressed tumor progression of the lung cancer from A549 cells and that decreased expression of Na+-K+ ATPase was involved in hypoxic inhibition of tumor progression. The results from this study provide new insights into the role of hypoxia in tumor progression and therapeutic strategies for cancer treatment.
在临床观察和动物研究中,缺氧已被确定为肿瘤进展的一个主要负面因素。然而,缺氧对肿瘤进展的确切作用尚未得到充分解释。在这项研究中,我们广泛研究了长期暴露于缺氧对体内肿瘤进展的影响。
将含有 A549 人肺癌细胞(肺癌肿瘤)的移植瘤的大鼠暴露于不同时间和不同程度的缺氧环境中。评估肿瘤生长和转移情况。我们还对 A549 肺癌细胞(A549 细胞)进行慢性缺氧处理,然后将预处理后的癌细胞植入小鼠体内。还研究了缺氧对小鼠Lewis 肺癌转移的影响。
我们发现,长期暴露于缺氧:a)显著抑制异种移植和大鼠原位模型中的肺癌肿瘤生长,b)显著减少肺癌的淋巴转移并降低小鼠Lewis 肺癌的肺转移,c)体外降低肺癌细胞增殖和细胞周期进展,d)降低缺氧预处理 A549 细胞的肿瘤生长,e)降低缺氧肺癌肿瘤中 Na+-K+ATPase α1 的表达,f)增加缺氧诱导因子(HIF1α 和 HIF2α)的表达,同时降低肺癌肿瘤中的微血管密度。与肺癌相反,HCT116 人结肠癌细胞(结肠癌肿瘤)的生长:a)在相同的缺氧条件下显著增强,b)Na+-K+ATPase α1 的表达无明显变化,c)HIF1α 表达增加(未检测到 HIF2α),d)肿瘤组织中的微血管密度增加。
本研究表明,长期暴露于缺氧抑制了 A549 细胞肺癌的肿瘤进展,而 Na+-K+ATPase 的表达降低参与了缺氧抑制肿瘤进展的过程。本研究的结果为缺氧在肿瘤进展中的作用以及癌症治疗的治疗策略提供了新的见解。